BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹7.22 Cr | ₹7.39 Cr | ₹2.57 Cr | ₹5.61 Cr | ₹4.74 Cr |
What is the latest Consolidated Net Profit of BAL PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹7.22 Cr |
| Mar2024 | ₹7.39 Cr |
| Mar2023 | ₹2.57 Cr |
| Mar2022 | ₹5.61 Cr |
| Mar2021 | ₹4.74 Cr |
How is Consolidated Net Profit of BAL PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹7.22 Cr | -2.39 | |
| Mar2024 | ₹7.39 Cr | 187.40 | |
| Mar2023 | ₹2.57 Cr | -54.17 | |
| Mar2022 | ₹5.61 Cr | 18.35 | |
| Mar2021 | ₹4.74 Cr | - | |
Compare Consolidated Net Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹114.2 Cr | -0.8% | -3.8% | -41.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -0.8% |
-3.8% |
-41.8% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses